PuriCore Signs Exclusive UK Distribution Agreement With Minntech Corporation To Expand Its Sterilox Endoscopy Portfolio

Published: Feb 05, 2007

PuriCore (LSE: PURI), the life sciences company focused on the development and commercialisation of its novel, safe antimicrobial technology, today announces that its Sterilox Endoscopy division has signed an exclusive distribution agreement with Minntech Corporation ("Minntech"), one of the world's leading manufacturers of automated endoscope reprocessors ("AER"), and a subsidiary of Cantel Medical Corp (NYSE: CMN).

Back to news